site search and site map


NACC
Homepage


What's
New?


IBD
Basics


About
NACC


Information
and Support


Contact
NACC


NACC
Groups


NACC
Members


NACC
Research


Fundraising
& Donations


Media
Room

Research Awards Archive

Research Awards since 2000 prior to 2005 are listed here in reverse date order (latest year first) sorted by the size of the grant.  The total for each year is shown at the end of that year's listings.

2005

Professor Christopher Mathew - Guys, King’s & St Thomas’ School of Medicine
Genetic investigation of the role of the NF-kB pathway in susceptibility to inflammatory bowel disease
£89,946 (2 years)
Paragraph marker bulletClick here for the lay summary           


Professor John Hermon-Taylor - St George’s Hospital Medical School, London
Progress in the development of a prime/boost MVA/Ad5 vectored vaccine against Mycobacterium avium subspecies paratuberculosis (MAP) to treat MAP-infected Crohn's disease sufferers
£89,242 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr Geoffrey Warhurst - University of Manchester
A novel role for P-glycoprotein in regulating the interaction between the colonic epithelium and commensal gut bacteria: implications for the pathogenesis of inflammatory bowel disease
£67,339 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr Miles Parkes - Addenbrooke’s Hospital
Cambridge and Eastern IBD genetics: expanding the large-scale region-wide IBD DNA panel; Genome Partitioning to map the IBD2 locus; and analysis of Crohn's disease data from Sanger Institute case/control study
£25,501 (18 months)
Paragraph marker bulletClick here for the lay summary           


Dr David Qualtrough - University of Bristol, School of Medical Sciences
The Role of Fascin in IBD related cancer risk
£5,756 (1 year)
Paragraph marker bulletClick here for the lay summary           


Research Awards for 2005 totalled: £277,784  

2004

Dr Satish Keshav - Department of Medicine, Royal Free & University College Medical School, London
Tissue-specific and circulating effectors in Crohn’s disease.
£85,000 (2 years)
Paragraph marker bulletClick here for the lay summary           


Professor Gordon Dougan - Centre for Molecular Microbiology and Infection, Dept.of Biological Sciences, Imperial College London, London
Isolation and characterisation of E.coli in inflammatory bowel disease.
£77,741 (2 years)
Paragraph marker bulletClick here for the lay summary           


Professor Derek Jewell - Gastroenterology Unit University of Oxford, Nuffield Dept. of Medicine, Radcliffe Infirmary, Oxford
Identification of a susceptibility gene on chromosome 3 for Crohn’s disease.
£75,000 (2 years)
Paragraph marker bulletClick here for the lay summary           


Professor Subrata Ghosh - Gastroenterology Section, Division of Medicine, Imperial College London, Hammersmith Hospital, London
A prospective study of the intestinal expression of vanilloid receptor 1 in symptomatic Crohn’s disease patients and its relationship to inflammation and Crohn’s Disease Activity Index score.
£42,500 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr Miles Parkes - Addenbrookes NHS Trust, Cambridge
Cambridge and Eastern region IBD genetics.
£41,455 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr John Mansfield - Royal Victoria Infirmary, Newcastle-upon-Tyne
Histological Correlation with Genetic Variation in Crohn’s Disease
£38,000 (1 year - Funded by the Margaret Sim Legacy)
Paragraph marker bulletClick here for the lay summary           


Research Awards for 2004 totalled: £359,696  

2003

Dr Barry Campbell - Gastroenterology Research Group, University Clinical Department of Medicine, Liverpool
Investigation of IL-8 release by mucosally-adherent E.coli and Bacteroides species relevant to pathogenesis of inflammatory bowel disease.
£76,790 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr Satish Keshav - Dept of Medicine, Royal Free and University College, London NW3 2PF
New targets in IBD: Crohn’s Disease, the NOD2 gene and Paneth cells.
£74,723 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr Jeremy Sanderson - Gastroenterology Department, St Thomas’s Hospital, London
Predictive Pharmacogenomics of Thiopurine Bowel Disease.
£36,812 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr Mark Pritchard - Department of Medicine, Liverpool University, Liverpool
Investigation of the importance of the gastrin family of peptides and gastrin/CCKB receptor in inflammatory bowel disease.
£29,887 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr Jeff Behrens - Lecturer, University of East Anglia, Norwich
Can Wireless Capsule Endoscopy be of use in assessing small bowel Crohn’s Disease ? – A pilot study assessing the possible role of colour as well as traditional computer vision methods to pathogenesis of Inflammatory Bowel Disease?
£5,995 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr Geoffrey Warhurst - Gut Barrier Group, Clinical Sciences Building, University of Manchester, Manchester
Colonic gene expression in a novel model of colitis: preliminary evaluation of the molecular mechanisms by which a primary defect is the mucosal barrier leads to IBD.
£5,920 (1 year)
Paragraph marker bulletClick here for the lay summary           


Research Awards for 2003 totalled: £230,127  

2002

Dr Peter Irving - Barts and The London School of Medicine and Dentistry
Platelet-Leucocyte Aggregation in Inflammatory Bowel Disease.
£79,809 (2 years)
Paragraph marker bulletClick here for the lay summary           


Professor Jack Satsangi - Gastrointestinal Laboratory, University of Edinburgh Dept. of Medical Sciences
Gene-environmental interactions in Inflammatory Bowel Disease: the effects of NOD-2 mutations and nicotine on NF-kB activation.
£76,775 (2 years)
Paragraph marker bulletClick here for the lay summary           


Professor Derek Jewell - Department of Gastroenterology, Oxford
Identification of the HLA susceptibility gene for colonic Crohn’s disease by targeted positional cloning and microarray expression studies.
£44,838 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr Timothy Card - School of Community Health Sciences, University Hospital, Nottingham
A very large population based study of the morbidity and mortality related to Inflammatory Bowel Diseases.
£28,542 (1 year)
Paragraph marker bulletClick here for the lay summary           


Miss Miranda Lomer - Gastrointestinal Research Laboratory, The Rayne Institute, St Thomas’ Hospital, London
Assessment of large pore (particulate) permeability: A pilot study.
£5,992 (2 months)
Paragraph marker bulletClick here for the lay summary           


Dr Satish Keshav - Dept of Medicine, Royal Free & University College Medical School, London
Chimeraplast-mediated gene therapy for Crohn’s Disease.
£5,800 (9 months)
Paragraph marker bulletClick here for the lay summary           


Research Awards for 2002 totalled: £241,756  

2001

Dr S Pender - Southampton General Hospital
Functional polymorphism in the regulatory region of matrix metalloproteinase genes in Inflammatory Bowel Diseases.
£74,202 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr J Cummings - University of Dundee
The toxicity of reduced sulphur compounds in the human large intestine: A novel approach to management of Ulcerative Colitis by dietary intervention.
£69,971 (conditional after 1 year)
Paragraph marker bulletClick here for the lay summary           


Dr H Burnett - Hope Hospital, Manchester
Magnetic Resonance Imaging of the terminal ileum using the TrueFISP sequence (True Fast Imaging with Steady Precession-2 weighted gradient echo), findings compared to small bowel enema (SBE).
£10,800 (9 months)
Paragraph marker bulletClick here for the lay summary           


Dr N Cook - Central Science Laboratory, York
Development of a NASBA-based method for detection of viable Mycobacterium paratuberculosis.
£6,000 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr S Keshav - Royal Free Hospital
Phosphoinositide-3-kinase ¡ expression in colorectal carcinoma associated with Inflammatory Bowel Disease.
£5,947 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr T Trebble - Southampton General Hospital
n-3 PUFA supplementation in paediatric Crohn’s Disease: effects on disease activity and growth.
£5,521 (6 months)
Paragraph marker bulletClick here for the lay summary           


Research Awards for 2001 totalled: £172,441  

2000

Dr D Rampton - Royal London Hospital
Adverse effects of oral iron therapy in IBD prevalence, mechanism and avoidance.
£74,655 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr S Bloom - Middlesex Hospital, London
Molecular analysis of colonic mucosal microflora associated with inflammatory bowel disease.
£35,527 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr S Middleton - Addenbrooke’s Hospital, Cambridge
Detection of mini chromosome maintenance proteins in stool samples and rectal lavage specimens. An alternative to surveillance colonoscopy in ulcerative colitis?
£35,500 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr D Robertson - Royal United Hospital, Bath
Investigating the contribution and possible interaction between NF-kB and P1-3 Kinase in the TNF- a induced signalling cascades in intestinal epithelial cells.
£6,000 (1 year)
Paragraph marker bulletClick here for the lay summary           


Mr O Ogunbiyi - Royal Free Hospital, London
Investigation of the relationship between inflammatory bowel disease and familial colorectal cancer.
£5,680 (2 years)
Paragraph marker bulletClick here for the lay summary           


Dr A Hart - West Norwich Hospital
The role of diet in the aetiology of Crohn’s disease and Ulcerative colitis - a pilot study in a European prospective cohort study.
£5,451 (1 year)
Paragraph marker bulletClick here for the lay summary           


Dr M Carter - Royal Hallamshire Hospital, Sheffield
Investigation of hyperhomocysteinemia as a cause of the increased risk of thrombosis in inflammatory bowel disease.
£4,000 (1 year)
Paragraph marker bulletClick here for the lay summary           


Research Awards for 2000 totalled: £166,813  

Quick Links on this page:

-Previous page

Welcome to the NACC website
Charity registered in England Number 1117148
Charity registered in Scotland Number SC038632
A company limited by guarantee in England: company number 5973370

Disclaimer

 
Problems downloading
from this site?

To access many of the downloads on this website you will need Adobe Acrobat Reader. This can be obtained free by clicking here or by clicking this image:
Get Adobe Acrobat Reader

Home  |  New  |  IBD  |  NACC  |  Services  |  Contact  |  Groups  |  Members  |  Research  |  Fundraising  |  Media

Copyright ©NACC 2004-2007
All information on this site is copyright and may not be reproduced without our express written consent


We would very much like to know what you think about the redesign of our website.
Please send your comments to the .  Thank you.
Site developed by Literate Systems